OneSource Specialty Pharma (NSE:ONESOURCE) Institutional Ownership: 25.21% (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONESOURCE OneSource Specialty Pharma Ltd NSE:ONESOURCE
8 GF Score
Price ₹1,483.60
! 3 Warning Signs
View Full Analysis

What is OneSource Specialty Pharma Institutional Ownership?

OneSource Specialty Pharma NSE:ONESOURCE -2.14% 8 Institutional Ownership is 25.21% as of Aug. 26, 2026. GuruFocus rates NSE:ONESOURCE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OneSource Specialty Pharma's institutional ownership is 25.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OneSource Specialty Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OneSource Specialty Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.

OneSource Specialty Pharma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for OneSource Specialty Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OneSource Specialty Pharma Institutional Ownership Chart

OneSource Specialty Pharma Historical Data

The historical data trend for OneSource Specialty Pharma can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 19.16 18.94 18.99 20.17 20.55 19.53 23.76 24.40 24.67 25.21
NSE:ONESOURCE
8GF Score
OneSource Specialty Pharma Ltd NSE:ONESOURCE
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OneSource Specialty Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 25.21% mean?
OneSource Specialty Pharma (NSE:ONESOURCE) has a Institutional Ownership of 25.21% as of Aug. 26, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OneSource Specialty Pharma and its competitors.
Is OneSource Specialty Pharma's Institutional Ownership too high?
OneSource Specialty Pharma's current Institutional Ownership is 25.21%. Overall, OneSource Specialty Pharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OneSource Specialty Pharma's Institutional Ownership compare to VRTX and REGN?
OneSource Specialty Pharma's Institutional Ownership of 25.21% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on OneSource Specialty Pharma and its competitors. OneSource Specialty Pharma's current Institutional Ownership is 25.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneSource Specialty Pharma stock overvalued right now?
OneSource Specialty Pharma (NSE:ONESOURCE) has a current Institutional Ownership of 25.21%. The current Institutional Ownership is 25.21%. OneSource Specialty Pharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For OneSource Specialty Pharma (NSE:ONESOURCE), the current Institutional Ownership is 25.21% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OneSource Specialty Pharma Business Description

Other Exchanges 544292:India
Address Bannerghatta Road, Star 1, Opp IIM Bangalore, Bilekahalli, Bangalore, KA, IND, 560076
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score

Get the complete analysis for NSE:ONESOURCE

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,483.60
Price